Nantahala Capital Management, LLC Uni Qure N.V. Transaction History
Nantahala Capital Management, LLC
- $2.22 Billion
- Q1 2025
A detailed history of Nantahala Capital Management, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 2,755,962 shares of QURE stock, worth $36.5 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
2,755,962
Previous 2,453,364
12.33%
Holding current value
$36.5 Million
Previous $43.3 Million
32.57%
% of portfolio
1.32%
Previous 2.18%
Shares
31 transactions
Others Institutions Holding QURE
# of Institutions
178Shares Held
50.7MCall Options Held
2.13MPut Options Held
480K-
Vestal Point Capital, LP New York, NY4.79MShares$63.5 Million3.63% of portfolio
-
Rtw Investments, LP New York, NY4.27MShares$56.5 Million0.74% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$52.9 Million3.32% of portfolio
-
Abrdn PLC2.22MShares$29.4 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.18MShares$28.8 Million0.37% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $619M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...